You are here: / / Business

Business

Get a Roundup of Psychedelic News Stories in Your Inbox.

    By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

    GH Research Is Taking its Psychedelic 5-MeO-DMT 'Toad Venom' Public

    GH Research Is Taking Psychedelic 5-MeO-DMT ‘Toad Venom’ Public

    GH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued at more than $100 million.
    AI Tech-Led Psychedelic Therapy Platform Nue Life Health Raises $3.3 Million

    AI Tech-Led Psychedelic Therapy Platform Nue Life Health Raises $3.3 Million

    Nue Life Health is a new therapy platform relying on AI and music as well as psychedelics for customized healing.
    Psychedelic Business News Spotlight

    Psychedelic Business Spotlight: June 4, 2021

    This week in psychedelic business: Mindset Pharma's new research, synthetic ibogaine, and the Western Hemisphere gets its first “smart shop.”
    'PSY' Becomes First U.S.-Listed Psychedelic ETF

    ‘PSY’ Becomes First U.S.-Listed Psychedelic ETF

    Defiance Next Gen Altered Experience ETF began trading Friday on the New York Stock Exchange under the symbol PSY.
    Psychedelic Business Spotlight: May 8, 2021

    Psychedelic Business Spotlight: May 28, 2021

    This week in psychedelic business news: NeonMind's Medical Advisory Board, Mynd's public listing, and a new study supports novel use of DMT.
    Psychedelic Platform Field Trip Health Gets Uplisting Conditional Approval for Toronto Stock Exchange

    Psychedelic Platform Field Trip Health Gets Uplisting Conditional Approval for Toronto Stock Exchange

    Psychedelic healing platform Field Trip Health has received conditional approval to uplist to the Toronto Stock Exchange.
    Psychedelic Drug Development Company Mynd Life Sciences Goes Public on the CSE

    Psychedelic Drug Development Company Mynd Life Sciences Goes Public on the CSE

    Psychedelic drug development company Mynd Life Sciences has gone public on the CSE.
    Enveric Biosciences Acquires Psychedelic Drug Discovery Platform MagicMed Industries

    Enveric Biosciences Acquires Psychedelic Drug Discovery Platform MagicMed Industries

    Cannabis-focused Enveric Biosciences will acquire Canadian psychedelic drug discovery platform MagicMed Industries.
    Psychedelic Business Spotlight: May 21, 2021

    Psychedelic Business Spotlight: May 21, 2021

    This week in psychedelic business news: Therapists cleared to try MDMA, alternative medicine guru promotes psychedelic therapy, and the Swiss green-light new mescaline study. On the heels of the recently released trial data showing how MDMA-assisted…
    Shark Tank’s Kevin O’Leary Deep Dives Into Psychedelics

    Shark Tank’s Kevin O’Leary Deep Dives Into Psychedelics

    Shark Tank investor Kevin O'Leary is a big fan of psychedelics. Here's everything you need to know.
    PharmaDrug Launches E-Store Positioned for U.S. Psychedelic Sales

    PharmaDrug Launches E-Store Positioned for U.S. Psychedelic Sales

    PharmaDrug is bringing an online shop to the U.S. for sales of functional mushrooms and psychedelics once legal.
    Business Spotlight

    Psychedelic Business News Spotlight: May 14, 2021

    This week in psychedelic business news: Therapeutic uses of salvinorin A, a 5-MeO-DMT retreat, and World Boxing Council explores psychedelics.
    Daniel Carcillo's Wesana Health Goes Public on CSE

    Daniel Carcillo’s Psychedelic Life Sciences Company Wesana Health Goes Public on CSE

    Daniel Carcillo's psychedelic life sciences company is now trading on the Canadian Securities Exchange.
    DMT-Focused Psychedelic Company Small Pharma Launches on TSX Venture Exchange

    DMT-Focused Psychedelic Company Small Pharma Launches on TSX Venture Exchange

    DMT-focused psychedelic therapy company Small Pharma is listing on the Canadian TSK Venture Exchange as it ramps up its offerings.
    Psychedelic Investment Platform Clarify Pharma to Go Public With £10.5 Million Valuation

    Psychedelic Investment Platform Clarify Pharma to Go Public With £10.5 Million Valuation

    The psychedelic investment platform Clarify Pharma is expecting to go public on the AQSE with a valuation of £10.5 million.
    Mike Tyson Invests In Psychedelic Wellness Company Wesana Health

    Mike Tyson Invests In Psychedelic Wellness Company Wesana Health

    ,
    Former heavyweight boxing champion Mike Tyson announced he's an investor in psychedelic wellness company Wesana Health.
    Psychedelic Business News Spotlight: May 7, 2021

    Psychedelic Business News Spotlight: May 7, 2021

    This week in psychedelic business news: LSD for pain, DMT and organ transplants, Champignon Brands is now Braxia Scientific Corp, and more.

    Canada Approves New Leaf’s Bid to Build First-Of-Its-Kind Psilocybin Lab

    New Leaf Canada has received permission from Health Canada to build a first-of-its-kind laboratory to produce and study psilocybin and psilocin.
    Psychedelic Companies Combine Forces to Create Virtual Reality Experience

    Psychedelic Companies Combine Forces to Create Virtual Reality Experience

    A new psychedelic VR experience is coming thanks to a partnership between Lobe Sciences and Virtual Psychedelics.
    Psychedelic Business News Spotlight: April 30, 2021

    Psychedelic Business News Spotlight: April 30, 2021

    This week in psychedelic business news: Cybin’s experimental psychedelic takes aim at alcohol use disorder, Numinus seeks volunteers for its natural psilocybin extract, and another psychedelic company trades on Nasdaq.  Toronto-based…
    Kevin O'Leary-Backed MindMed Is 2nd Psychedelic Company to List On Nasdaq

    Kevin O’Leary-Backed MindMed Will Be 2nd Psychedelic Company to List On Nasdaq

    MindMed will take its Kevin O'Leary-backed platform onto the Nasdaq Tuesday as only the 2nd psychedelic company to do so.
    Psychedelic Business News Spotlight: April 23, 2021

    Psychedelic Business News Spotlight: April 23, 2021

    This week in psychedelic business news: Atai to raise $100 million, Silo's psilocybin nasal spray, and more.
    Psychedelic Start-Up Atai Life Sciences to Raise $100 Million in IPO, 2nd to List on Nasdaq

    Psychedelic Start-Up Atai Life Sciences to Raise $100 Million in IPO, 2nd to List on Nasdaq

    Atai Life Sciences is now the second psychedelic company to list on Nasdaq, with plans to raise $100 million for its IPO.
    Psychedelic Business News Spotlight: April 16, 2021

    Psychedelic Business News Spotlight: April 16, 2021

    This week in psychedelic business news:psilocybin’s genome sequencing explored, psychedelics meet artificial intelligence, and more.
    GH Research Raises $125 Million to Fund DMT Treatment for Depression

    GH Research Raises $125 Million to Fund DMT Treatment for Depression

    GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment.
    psychedelic mushrooms

    Silo Wellness Expands Shareholder Base to Europe

    Toronto's Silo Wellness is now trading on the German Stock Exchange as demand for psychedelic treatments expands.

    Daniel Carcillo’s Psychedelic Startup Wesana Health Raises More Funds, On Track to Go Public

    ,
    Former NHL player Daniel Carcillo's psychedelic startup Wesana Health is preparing to take the company public.
    Psychedelic Business News Spotlight: April 9, 2021

    Psychedelic Business News Spotlight: April 9, 2021

    This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic test to predict your psychedelic-assisted therapy experience, and a potential first treatment for a debilitating form of schizophrenia.
    Mydecine Prepares to Present Four Novel Psychedelic Candidates

    Mydecine Prepares to Present Four Novel Psychedelic Candidates

    ,
    Colorado-based Mydecine is launching four new psychedelic candidates for use in treating conditions like anxiety and depression.
    Psychedelic Business News Spotlight: April 2, 2021

    Psychedelic Business News Spotlight: April 2, 2021

    This week in psychedelic business news: cannabis dives in, ketamine delivery, and psilocybin for autism anxiety.
    How Field Trip Health Is Leading the Psychedelic Market Boom

    How Field Trip Health Is Leading the Psychedelic Market Boom

    Field Trip Health is brining psychedelics to the forefront of mental health wellness.
    Psychedelic Business News Spotlight: March 26, 2021

    Psychedelic Business News Spotlight: March 26, 2021

    This week in psychedelic business news sees pharmaceutical giant Merck enter the arena, psilocybin research, and more.
    Psychedelic Business News Spotlight: March 18, 2021

    Psychedelic Business News Spotlight: March 19, 2021

    This week in psychedelic business news, quick dissolve LSD, novel psychedelic molecules move into investigational studies, and more.
    These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

    These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

    ,
    Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.
    How The Conscious Fund Is Changing Perceptions About Psychedelics

    How The Conscious Fund Is Changing Perceptions About Psychedelics

    UK venture capital fund The Conscious Fund is working to make psychedelics more accessible and functional in various capacities.
    Psychedelic Business News Spotlight: March 12, 2021

    Psychedelic Business News Spotlight: March 12, 2021

    This week in psychedelic business news, Canada expands legal distribution for psychedelics, therapeutic DMT stroke treatment, and more.
    Canada Expands Psychedelic Approvals for Numinus

    Canada Expands Psychedelic Approvals for Numinus

    Numinus Biosciences has received expanded regulatory approval in Canada for psychedelic use and distribution.
    North America Is Poised to Take the Lead In Emerging Psychedelic Drug Market

    North America Is Poised to Take the Lead In Emerging Psychedelic Drugs Market

    ,
    The psychedelic drugs market is finding a strong base in North America, according to new data. The U.S. and Canada in particular are supporting its expansion.
    New App Creates Psychedelic Experience Without the Need for Substances

    Can An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says Yes

    ,
    Lumenate is an app that simulates a psychedelic experience without the need for illegal substances.
    Defiance Just Launched the World's Second Psychedelic-Focused ETF

    Defiance Just Launched the World’s Second Psychedelics-Focused ETF

    Defiance has launched the world's second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.
    Psychedelic Business News Spotlight: March 5, 2021

    Psychedelic Business News Spotlight: March 5, 2021

    This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.
    Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion

    Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion

    Biotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental health issues.
    Psychedelic Business News Spotlight: February 26, 2021

    Psychedelic Business News Spotlight: February 26, 2021

    This week in psychedelic business news, Field Trip upsizes its bought deal, psilocybin truffles head to Brazil, another company goes public, and more.
    First Of Its Kind $10 Million Psychedelic Research Center Comes to NYU

    ‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

    ,
    NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.
    Psychedelic Business News Spotlight: February 19, 2021

    Psychedelic Business News Spotlight: February 19, 2021

    This week in psychedelic business news: MindMed acquires a digital health company, Mindest Pharma goes public, new MDMA treatment for PTSD, and more.
    Psychedelic Spotlight Business News

    Psychedelic Business News Spotlight: February 12, 2021

    This week in Psychedelic business news: MindMed has a new partner, Mydecine closes a funding round, and the world’s first legal psilocybin cultivation facility launches.
    Psychedelic Business Spotlight: February 5, 2021

    Psychedelic Business News Spotlight: February 5, 2021

    This week in psychedelic business news, Super Mario's magic mushroom gets a new use, Mindset files three patents, Bright Minds goes public, and more.
    5meo-dmt

    5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

    , ,
    Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief from a number of mental health issues including depression.
    psyk etf

    The World’s First Psychedelic ETF Just Launched: Here’s Why That Matters

    The Horizons Psychedelic ETF launched on the Canadian NEO stock exchange last month. Here's what that means for the industry, and the future.
    psilocybin truffles

    How Red Light Holland Is Bringing Psilocybin Truffles Mainstream

    ,
    Canada's Red Light Holland is preparing to take its psilocybin truffles global as demand for psychedelics heats up.
    neon mind

    Psychedelic Business News Spotlight: January 29, 2021

    This week in psychedelic business news, Psyence Group's psilocybin harvest, NeonMind's new CEO, and Mydecine sponsors new research.
    Psychedelic Business News Spotlight: January 22, 2021

    Psychedelic Business News Spotlight: January 22, 2021

    This week in psychedelic industry news: the first psychedelic stock index, new products, mergers, and funds.

    Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic Research

    ,
    Wesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue its psychedelic research for traumatic brain injuries.
    Psychedelic Business News Spotlight: January 15, 2021

    Psychedelic Business News Spotlight: January 15, 2021

    This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.
    Psychedelic Business News

    Psychedelic Business News Spotlight: January 08, 2021

    This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.
    NeonMind Takes Psilocybin Therapy Public

    NeonMind Takes Psilocybin Therapy Public

    NeonMind is the latest psychedelic company to go public. It's the first to launch on the Canadian Stock Exchange in 2021.
    5 Psychedelic Apps

    These 5 Apps Are Made for Taking Psychedelics

    ,
    Taking psychedelics? There's an app for that. These companies are leading the way with trip guides, support, and more.
    Psychedelic Trend Predictions 2021

    7 Psychedelic Trend Predictions for 2021

    The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger and better year for the industry.
    UK psychedelic VC fund

    Psychedelic Business News Spotlight: December 17, 2020

    The UK gets its first psychedelic VC fund, psychedelic treatment for Parkinson's, and more business news.

    Psychedelic Business News Spotlight: December 10, 2020

    This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.
    Singapore Begins Administering Ketamine-Type Therapy for Depression

    Psychedelic Life Science Company Cybin Acquires Ketamine Drug Maker Adelia Therapeutics

    Cybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major acquisition.
    Psychedelic Business News Spotlight

    Psychedelic Business News Spotlight: December 3, 2020

    This week in psychedelic business news: Numimus Wellness Inc. annouces a major partnership, Field Trip expands its investor relations, serial entrepreneur Peter Thiel invests in psychedelics for mental health treatment, and more. Numimus…
    Peter Thiel Invests $12 Million In Psychedelic Drug Manufacturer

    Peter Thiel Invests $12 Million In Psychedelic Drug Manufacturer

    Billionaire tech investor Peter Thiel is the latest to join the booming psychedelic industry. The PayPal co-founder backed Berlin’s ATAI Life Sciences in a $125 million series C funding round. Thiel’s investment firm, Thiel Capital,…
    Psychedelic Tech Company Cybin Brings In a $45 Million

    Psychedelic Tech Company Cybin Brings In a $45 Million (CAD) Funding Round

    Canadian pharmaceutical therapies company Cybin announced $45 million (CAD) in gross proceeds on a private placement of 60,000,000 subscription receipts as part of a new funding round. The company will use the funds to further expand its development…
    Dr. Andrew Weil Joins Advisory Board for Psychedelic Therapy Platform

    Dr. Andrew Weil Joins Advisory Board for Psychedelic Therapy Platform Field Trip

    Acclaimed integrative medicine pioneer, Dr. Andrew Weil, has joined the advisory board for psychedelic therapy platform Field Trip Health. “I am extremely pleased to be joining the medical advisory board at Field Trip,” Dr. Weil…
    Field Trip Is the Latest Psychedelic Therapy Company to Go Public

    Field Trip Is the Latest Psychedelic Therapy Company to Go Public

    Another psychedelic therapy-based company has gone public. Toronto-based Field Trip Health Ltd., which operates the mobile therapy app Trip, is now trading on the Canadian Securities Exchange under the symbol FTRP. Psychedelic therapy for…
    Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing

    Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing

    Just days after UK-based psychedelic developer Compass Pathways went public, New York-based MindMed has applied for a Nasdaq up-listing. The company, valued at $190 million,  is already listed on Canada’s NEO exchange. MindMed…
    Compass Pathways IPO Brings $1 Billion Valuation

    Compass Pathways IPO Brings $1 Billion Valuation

    UK-based Compass Pathways led a groundbreaking IPO last week. Share prices spiked 71 percent to nearly $30 after the initial offering of 7.5 million shares, which launched at $17 each. Current value of the company based on its 34 million shares…
    Investors Are Betting On Psychedelics

    Why Investors Are Betting On Psychedelics

    While they’ve historically brought the risk of long jail sentences, psychedelics are now bringing another long-term scenario: big-time investments. The potential for psychedelics in treating mental disorders such as depression, suicidal…
    The Psychedelic Medicine Association

    The Psychedelic Medicine Association Launches to Align the Industry

    A first of its kind, The Psychedelic Medicine Association (PMA) is set to launch on September 29th. The association aligns medical establishments, patients, and industry leaders in the advancement of psychedelic therapy. “We want physicians…
    Quick-Dissolve Strips to Psychedelics

    New Partnership Will Bring Quick-Dissolve Strips to Psychedelics

    Psychedelic drugs could soon have a standardized, and much faster delivery method with the announcement last month that ATAI Life Sciences AG and IntelGenx have entered into an agreement to develop polymeric film technologies. The…
    CEO of Canadian Stock Exchange on Psychedelic Investments

    CEO of Canadian Stock Exchange on Psychedelic Investments

    Listening to Richard Carleton – the CEO of the Canadian Securities Exchange – talk about future investment opportunities in the psychedelic space, you come away with two thoughts: The differences between cannabis and psychedelics are stark,…
    Canadian Manufacturer Licensed to Make Psilocybin

    Canadian Manufacturer Licensed to Make Psilocybin

    Vancouver-based Mydecine Innovations Group, Inc., has become the first company to earn the license to legally produce and distribute pharmaceutical-grade psilocybin in Canada, the company announced last month. Mydecine, which also has offices…
    Low Doses of LSD Make Opioids Obsolete

    Could Low Doses of LSD Make Opioids Obsolete?

    Better known for its psychedelic properties, Lysergic Acid Diethylamide (LSD) became extremely popular during the counterculture of the 1960’s. But it wasn’t only popular among the free-loving hippies... What most people fail to realize…
    Quest For A Market-Friendly Synthetic Psilocybin

    The Quest For A Market-Friendly Synthetic Psilocybin Is Decades In The Making

    Exactly 65 years ago, R. Gordon Wasson, a vice president of J.P. Morgan & Co., leaned over the desk of the highest ranking official in a remote Mexican Indian village high atop the Mixeteco mountains and whispered, “Will you help me learn…
    © 2021 Psychedelic Spotlight. All rights reserved. Owned and operated by Global Trac Solutions, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.